Medicinal applications of fullerenes

International Journal of Nanomedicine

Volumn 2, Issue 4, 2007, Pages 639-649

  Bakry, Rania ^a   Vallant, Rainer M ^a   Najam ul Haq, Muhammad ^a   Rainer, Matthias ^a   Szabo, Zoltan ^a   Huck, Christian W ^a   Bonn, Günther K ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Antioxidants; Diagnostic; Drug delivery; Fullerenes; Photosensitizer

Indexed keywords

ANTIOXIDANT; CARBON; DNA BASE; FULLERENE DERIVATIVE; PACLITAXEL; PHOTOSENSITIZING AGENT; PLASMA PROTEIN; PROTEINASE; SCAVENGER; SINGLET OXYGEN;

ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; CATALYSIS; CONTRAST ENHANCEMENT; DERIVATIZATION; DIAGNOSTIC VALUE; DNA CLEAVAGE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG SOLUBILITY; DRUG STRUCTURE; ELECTROCHEMISTRY; ELECTRON TRANSPORT; ELECTRONICS; ENZYME SUBSTRATE; GENE DELIVERY SYSTEM; HYDROPHOBICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHOTOCHEMISTRY; PHOTOSENSITIZATION; PHYSICAL CHEMISTRY; PROTEIN ANALYSIS; QUANTUM YIELD; REVIEW; SCAVENGING SYSTEM; TOXICITY TESTING;

ANTIOXIDANTS; DRUG CARRIERS; FULLERENES; GENE THERAPY; NANOMEDICINE; NANOSTRUCTURES;

EID: 46149113117     PISSN: 11769114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. An YZ, Chen CHB, Anderson JL, et al. 1996. Sequence-specific modification of guanosine in DNA by a C60-linked deoxyoligonucleotide: evidence for a non-singlet oxygen mechanism. Tetrahedron, 52:5179-89.
2. Azzam T, Domb AJ. 2004. Current developments in gene transfection agents. Curr Drug Deliv, 1:165-93.
3. Bensasson RV, Bienvenue E, Dellinger M, et al. 1994. C60 in model biological systems. A visible-UV absorption study of solvent-dependent parameters and solute aggregation. J Phys Chem, 98:3492-500.
4. Bianco A, Maggini M, Scorrano G, et al. 1996. Synthesis, chiroptical properties, and configurational assignment of fulleroproline derivatives and peptides. J Am Chem Soc, 118:4072-80.
5. Bisaglia M, Natalini B, Pellicciari R, et al. 2000. C3-fullero-trismethanodicarboxylic acid protects cerebellar granule cells from apoptosis. J Neurochem, 74:1197-204.
6. Bosi S, Da Ros T, Spalluto G, et al. 2003. Synthesis and Anti-HIV properties of new water-soluble bis-functionalized [60]fullerene derivatives. Bioorg Med Chem Lett, 13:4437-40.
7. Brettreich M, Hirsch A. 1998. A highly water-soluble dendro[60]fullerene. Tetrahedron Lett, 39:2731-34.
8. Cao B, Suenaga K, Okazaki T, et al. 2002. Production, Isolation, and EELS characterization of Ti2Γ84 dititanium metallofullerenes. J Phys Chem B, 106:9295-8.
9. Chen HH, Yu C, Ueng TH, et al. 1998. Acute and subacute toxicity study of water-soluble polyalkylsulfonated C60 in rats. Toxicol Pathol, 26:143-51.
10. Chen Y, Cai RF, Chen S, et al. 2001. Synthesis and characterization of fullerol derived from C60n- precursors. J Phys Chem Solids, 62:999-1001.
11. Chen YW, Hwang KC, Yen CC, et al. 2004. Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs. Am J Physiol Regal Integr Comp Physiol, 287:R21-6.
12. Da Ros T, Spalluto G, Prato M. 2001. Biological applications of fullerene derivatives: a brief overview. Croatica Chem Acta, 74:743-55.
13. 82. Chem Phys Lett, 261:92-7.
14. Dugan LL, Turetsky DM, Do C, et al. 1997. Carboxyfullerenes as neuroprotective agents. Proc Nat Acad Sci USA, 94:9434-9.
15. Feuerstein I, Najam-ul-Haq M, Rainer M, et al. 2006. Material-enhanced laser desorption/ionization (MELDI)-a new protein profiling tool utilizing specific carrier materials for time of flight mass spectrometric analysis. J Am Soc Mass Spectrom, 17:1203-8.
16. Foley S, Crowley C, Smaihi M, et al. 2002. Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Commun, 294:116-19.
17. Fowler PW, Ceulemans A. 1995. Electron deficiency of the fullerenes. J Phys Chem, 99:508-10.
18. Friedman SH, DeCamp DL, Sijbesma RP, et al. 1993. Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification. J Am Chem Soc, 115:6506-9.
19. Gharbi N, Pressac M, Hadchouel M, et al. 2005. [60]Fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett, 5:2578-85.
20. Halliwell B. 1992. Reactive oxygen species and the central nervous system. J Neurochem, 59:1609-23.
21. Hetzer M, Bayerl S, Camps X, et al. 1997. Fullerenes in membranes. Structural and dynamic effects of lipophilic C60 derivates in phospholipid bilayers. Adv Mater, 9:913-17.
22. Hirsch A, Lamparth I, Groesser T, et al. 1994. Regiochemistry of multiple additions to the fullerene core: synthesis of a Th-symmetric hexakis adduct of C60 with Bis(ethoxycarbonyl)methylene. J Am Chem Soc, 116:9385-6.
23. Huang YL, Shen CK, Luh TY, et al. 1998. Blockage of apoptotic signaling of transforming growth factor-beta in human hepatoma cells by carboxyfullerene. Eur J Biochem, 254:38-43.
24. Iezzi EB, Duchamp JC, Harich K, et al. 2002. A symmetric derivative of the trimetallic nitride endohedral metallofullerene, Sc3NΓ80. J Am Chem Soc, 124:524-5.
25. Isobe H, Nakanishi W, Tomita N, et al. 2006. Nonviral gene delivery by tetraamino fullerene. Mol Pharm, 3:124-34.
26. Isobe H, Nakanishi W, Tomita N, et al. 2006. Gene delivery by aminofullerenes: structural requirements for efficient transfection. Chem-An Asian J, 1:167-75.
27. Isobe H, Tomita N, Jinno S, et al. 2001. Synthesis and transfection capability of multi-functionalized fullerene polyamine. Chem Lett, 12:1214-15.
28. Iwamoto Y, Yamakoshi Y. 2006. A highly water-soluble C60-NVP copolymer: a potential material for photodynamic therapy. Chem Commun, 46:4805-7.
29. Ji, ZQ, Sun H, Wang H, et al. 2006. Biodistribution and tumor uptake of C60(OH)x in mice. J Nanoparticle Res, 8:53-63.
30. Kaesermann F, Kempf C. 1997. Photodynamic inactivation of enveloped viruses by buckminsterfullerene. Antiviral Res, 34:65-70.
31. Karam LR, Mitch MG, Coursey BM. 1997. Encapsulation of 99mTc within fullerenes: a novel radionuclidic carrier. App Rad Isotopes, 48:771-6.
32. Kotelnikova RA, Bogdanov GN, Frog EC, et al. 2003. Nanobionics of pharmacologically active derivatives of fullerene C60. J Nanoparticle Res, 5:561-6.
33. Kraetschmer W, Lamb LD, Fostiropoulos K, et al. 1990. Solid C60: a new form of carbon. Nature, 347:354-8.
34. Kroto HW, Heath JR, O'Brien SC, et al. 1985. C60: buckminsterfullerene. Nature, 318:162-3.
35. Krusic PJ, Wasserman E, Keizer PN, et al. 1991. Radical reactions of C60. Science, 254:1183-5.
36. Li J, Yang Y, Liu J, et al. 2005. Synthesis of [14C] quincetone. J Radioanal Nuc Chem, 265:17-20.
37. Lin AM, Chyi BY, Wang SD, et al. 1999. Carboxyfullerene prevents iron-induced oxidative stress in rat brain. J Neurochem, 72:1634-40.
38. Lin AMY, Fang SF, Lin SZ, et al. 2002. Local carboxyfullerene protects cortical infarction in rat brain. Neurosci Res, 43:317-21.
39. Liu J, Ohta S, Sonoda A, et al. 2007. Preparation of PEG-conjugated fullerene containing Gd3+ ions for photodynamic therapy. J Controlled Release, 117:104-10.
40. Liu S, Sun S. 2000. Recent progress in the studies of endohedral metallofullerenes. J Organometallic Chem, 599:74-86.
41. Lotharius J, Dugan LL, O'Malley KL. 1999. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci, 19:1284-93.
42. Marchesan S, Da Ros T, Spalluto G, et al. 2005. Anti-HIV properties of cationic fallerene derivatives. Bioorg Med Chem Lett, 15:3615-18.
43. Marcorin GL, Da Ros T, Castellano S, et al. 2000. Design and synthesis of novel [60]Fullerene derivatives as potential HIV aspartic protease inhibitors. Org Lett, 2:3955-8.
44. Mashino T, Shimotohno K, Ikegami N, et al. 2005. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives. Bioorg Med Chem Lett, 15:1107-9.
45. Monti D, Moretti L, Salvioli S, et al. 2000. C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells. Biochem Biophys Res Commun, 277:711-17.
46. Mori T, Takada H, Ito S, et al. 2006. Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis. Toxicology, 225:48-54.
47. Mroz P, Pawlak A, Satti M, et al. 2007. Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radical Biol Med, 43:711-719.
48. Moussa F, Pressac M, Hadchouel M, et al. 1997. Fullerenes: recent advances in the chemistry and physics of fullerenes and related materialsp 332-40.
49. Nakamura E, Isobe H. 2003. Functionalized fullerenes in water, the first 10 years of their chemistry, biology, and nanoscience. Acc Chem Res, 36:807-15.
50. Prato M. 1997. [60]Fullerene chemistry for materials science applications. J Mater Chem, 7:1097-09.
51. Rainer M, Muhammad NU, Huck CW, et al. 2006. Ultra-fast mass fingerprinting by high-affinity capture of peptides and proteins on derivatized poly(glycidyl methacrylate/divinylbenzene) for the analysis of serum and cell lysates. Rapid Commun Mass Spectrom, 20:2954-60.
52. Rancan F, Rosan S, Boehm F, et al. 2002. Cytotoxicity and photocytotoxicity of a dendritic C60 mono-adduct and a malonic acid C60 tris-adduct on Jurkat cells. J Photochem Photobiol B 67:157-62.
53. Romanova VS, Tsyryapkin VA, Lyakhovetsky YI, et al. 1994. Addition of amino acids and dipeptides to fullerene C60 giving rise to monoadducts. Izvestiya Akademii Nauk, Seriya Khimicheskaya, 6:1154-5.
54. Rouse JG, Yang J, Ryman-Rasmussen JP, et al. 2007. Effects of mechanical flexion on the penetration of fallerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett, 7:155-60.
55. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. 2006. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci, 91:159-65.
56. Rywkin S, Ben-Hur E, Reid ME, et al. 1995. Selective protection against IgG binding to red cells treated with phthalocyanines and red light for virus inactivation. Transfusion, 35:414-20.
57. Satoh M, Matsuo K, Kiriya H, et al. 1997. Inhibitory effects of a fullerene derivative, dimalonic acid C60, on nitric oxide-induced relaxation of rabbit aorta. Eur J Pharmacol, 327:175-81.
58. Sayes CM, Fortner JD, Guo W, et al. 2004. The differential cytotoxicity of water-soluble fullerenes. Nano Lett, 4:1881-7.
59. Schuster DI, Wilson SR, Kirschner AN, et al. 2000. Evaluation of the anti-HIV potency of a water-soluble dendrimeric fullerene. Proc Electrochem Soc, 9:267-70.
60. Scrivens WA, Tour JM, Creek KE, et al. 1994. Synthesis of 14C-labeled C60, its suspension in water, and its uptake by human keratinocytes. J Am Chem Soc, 116:4517-18.
61. Shinkai S, Ikeda A. 1998. Calixarene-fullerene conjugates: marriage of the third generations of inclusion compounds and carbon clusters. Gazzetta Chimica Italiana, 127:657-62.
62. Sijbesma R, Srdanov G, Wudl F, et al. 1993. Synthesis of a fullerene derivative for the inhibition of HIV enzymes. J Am Chem Soc, 115:6510-12.
63. Slater TF, Cheeseman KH, Ingold KU. 1985. Carbon tetrachloride toxicity as a model for studying free-radical mediated liver injury. Philos Trans R Soc Lond B Biol Sci, 311:633-45.
64. Stevenson S, Rice G, Glass T, et al. 1999. Small-bandgap endohedral metallofullerenes in high yield and purity. Nature, 401:55-7.
65. Straface E, Natalini B, Monti D, et al. 1999. C3-Fullero-tris-methanodicarboxylic acid protects epithelial cells from radiation-induced anoikia by influencing cell adhesion ability. FEBS Lett, 454:335-40.
66. Taylor R, Hare JP, Abdul-Sada AK, et al. 1990. Isolation, separation and characterization of the fullerenes C60 and C70: the third form of carbon. J Chem Soc Chem Commun, 20:1423-5.
67. Thrash TP, Cagle DW, Alford JM, et al. 1999. Toward fullerene-based radiopharmaceuticals: high-yield neutron activation of endohedral 165Ho metallofullerenes. Chem Phys Lett, 308:329-36.
68. Tsai MC, Chen YH, Chiang LY. 1997. Polyhydroxylated C60, fullerenol, a novel free-radical trapper, prevented hydrogen peroxide- and cumene hydroperoxide-elicited changes in rat hippocampus in vitro. J Pharm Pharmacol, 49:438-45.
69. Tsuchiya T, Yamakoshi YN, Miyata N. 1995. A novel promoting action of fullerene C60 on the chondrogenesis in rat embryonic limb bud cell culture system. Biochem Biophy Res Commun, 206:885-94.
70. Vallant RM, Szabo Z, Trojer L, et al. 2007. A new analytical material-enhanced laser desorption ionization (MELDI) based approach for the determination of low-mass serum constituents using fullerene derivatives for selective enrichment. J Proteome Res, 6:44-53.
71. Xiao L, Takada H, Gan XH, et al. 2006. The water-soluble fullerene derivative 'Radical Sponge' exerts cytoprotective action against UVA irradiation but not visible-light-catalyzed cytotoxicity in human skin keratinocytes. Bioorg Med Chem Lett, 16:1590-5.
72. Xu ZP, Zeng QH, Lu GQ et al. 2005. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci, 61:1027-40.
73. Yamago S, Tokuyama H, Nakamura E, et al. 1995. In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. Chem Biol, 2:385-9.
74. Yamakoshi Y, Umezawa N, Ryu A, et al. 2003. Active Oxygen Species Generated from Photoexcited Fullerene (C60) as Potential Medicines: O-.bul.2 versus 102. J Am Chem Soc, 125:12803-9.
75. Yamakoshi YN, Yagami T, Fukuhara K, et al. 1994. Solubilization of fullerenes into water with poly(vinylpyrrolidone) applicable to biological tests. J Chem Soc Chem Commun, 4:517-18.
76. Yamakoshi YN, Yagami T, Sueyoshi S, et al. 1996. Acridine adduct of [60]fullerene with enhanced DNA-cleaving activity. J Org Chem, 61:7236-7.
77. Youle RJ, Karbowski M. 2005. Opinion: mitochondrial fission in apoptosis. Nature Rev Mol Cell Biol, 6:657-63.
78. Zakharian TY, Seryshev A, Sitharaman B, et al. 2005. A Fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture. J Am Chem Soc, 127:12508-9.
79. Zhu Z, Schuster DI, Tuckerman ME. 2003. Molecular dynamics study of the connection between flap closing and binding of fullerene-based inhibitors of the HIV-1 protease. Biochem, 42:1326-33.